Literature DB >> 2546542

Identification and characterization of endothelin binding sites in rat renal papillary and glomerular membranes.

E R Martin1, P A Marsden, B M Brenner, B J Ballermann.   

Abstract

The present study was designed to identify and characterize specific endothelin binding sites in membranes of rat renal papillae and glomeruli which appear to be target tissues for this new peptide hormone. Saturation binding studies indicate that the sites have a high and uniform affinity. The dissociation constants averaged 662 +/- 151 and 1309 +/- 123 pM and the receptor densities 7666 +/- 920 and 5831 +/- 348 fmol/mg protein for papillary and glomerular membranes, respectively. Endothelin 1, endothelin 3 and sarafotoxin all inhibited [125I]-endothelin binding with IC50's in the 100-300 pM range, whereas unrelated peptides, namely angiotensin II, atrial natriuretic peptide, and platelet-derived growth factor failed to compete for [125I]-endothelin binding. Deletion of the carboxyterminal tryptophan in endothelin 1 reduced its affinity for glomerular binding sites by 2 orders of magnitude. Specific endothelin binding to these membranes was maximal at pH 4 and was markedly inhibited as the pH was raised above 8. When [125I]-endothelin is covalently linked to glomerular membrane binding sites, SDS-PAGE of these solubilized membranes followed by autoradiography reveals a predominant specifically labeled band of 45 kDa. Whether this band represents a subunit of the endothelin receptor(s), the receptor proper, or an intracellular endothelin binding protein remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2546542     DOI: 10.1016/0006-291x(89)91972-4

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Endothelin inhibits vasopressin-stimulated water permeability in rat terminal inner medullary collecting duct.

Authors:  S P Nadler; J A Zimpelmann; R L Hébert
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

Review 2.  Endothelium-dependent vascular responses. Mediators and mechanisms.

Authors:  B M Brenner; J L Troy; B J Ballermann
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

3.  Design and synthesis of a specific endothelin 1 antagonist: effects on pulmonary vasoconstriction.

Authors:  M J Spinella; A B Malik; J Everitt; T T Andersen
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

4.  Role of endogenous endothelin in renal haemodynamics of newborn rabbits.

Authors:  D S Semama; M Thonney; J P Guignard
Journal:  Pediatr Nephrol       Date:  1993-12       Impact factor: 3.714

5.  Localization and quantification of [125I]-endothelin binding sites in human fetal and adult kidneys--relevance to renal ontogeny and pathophysiology.

Authors:  H J Gröne; A Laue; E Fuchs
Journal:  Klin Wochenschr       Date:  1990-08-02

6.  Luminal and basolateral endothelin inhibit chloride reabsorption in the mouse thick ascending limb via a Ca(2+)-independent pathway.

Authors:  M C de Jesus Ferreira; C Bailly
Journal:  J Physiol       Date:  1997-12-15       Impact factor: 5.182

7.  Endothelin stimulates phosphatidylinositol hydrolysis and DNA synthesis in brain capillary endothelial cells.

Authors:  P Vigne; R Marsault; J P Breittmayer; C Frelin
Journal:  Biochem J       Date:  1990-03-01       Impact factor: 3.857

8.  Endothelin action in rat liver. Receptors, free Ca2+ oscillations, and activation of glycogenolysis.

Authors:  C Serradeil-Le Gal; C Jouneaux; A Sanchez-Bueno; D Raufaste; B Roche; A M Préaux; J P Maffrand; P H Cobbold; J Hanoune; S Lotersztajn
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

9.  Hepatic effects of endothelin. Receptor characterization and endothelin-induced signal transduction in hepatocytes.

Authors:  C R Gandhi; R H Behal; S A Harvey; T A Nouchi; M S Olson
Journal:  Biochem J       Date:  1992-11-01       Impact factor: 3.857

10.  Failure of BQ123, a more potent antagonist of sarafotoxin 6b than of endothelin-1, to distinguish between these agonists in binding experiments.

Authors:  J J Maguire; R E Kuc; B A Rous; A P Davenport
Journal:  Br J Pharmacol       Date:  1996-05       Impact factor: 8.739

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.